Trial: New Pill Nearly Doubles Survival Time for Pancreatic Cancer Patients

A clinical trial showed that the drug daraxonrasib nearly doubled survival time for patients with advanced pancreatic cancer. Experts are calling the pill a potential 'gamechanger' with fewer side effects than chemotherapy.